| 1 |
孙圣坤，杨树军，卫浩，等. 走向临床的异种器官移植[J]. 器官移植，2024, 15(2): 200-206.
|
| 2 |
Arabi TZ, Sabbah BN, Lerman A, et al. Xenotransplantation: current challenges and emerging solutions[J]. Cell Transplant, 2023, 32: 9636897221148771.
|
| 3 |
窦科峰，张玄，陶开山. 异种移植存在的问题及国内发展现状[J]. 空军军医大学学报，2024, 45(1): 1-4.
|
| 4 |
Xing K, Chang Y, Zhang X, et al. Xenotransplantation in China: past, present, and future[J]. Xenotransplantation, 2025, 32(2): e70038.
|
| 5 |
Lai L, Kolber-Simonds D, Park KW, et al. Production of alpha-1，3-galactosyltransferase knockout pigs by nuclear transfer cloning[J]. Science, 2002, 295(5557): 1089-1092.
|
| 6 |
Phelps CJ, Koike C, Vaught TD, et al. Production of alpha 1，3-galactosyltransferase-deficient pigs[J]. Science, 2003, 299(5605): 411-414.
|
| 7 |
Niu D, Wei HJ, Lin L, et al. Inactivation of porcine endogenous retrovirus in pigs using CRISPR-Cas9[J]. Science, 2017, 357(6357): 1303-1307.
|
| 8 |
中国科学报． 全球首例LXRα基因编辑猪诞生[EB/OL]. (2026-03-30) [2026-06-14].
URL
|
| 9 |
Pan D, Liu T, Lei T, et al. Progress in multiple genetically modified minipigs for xenotransplantation in China[J]. Xenotransplantation, 2019, 26(1): e12492.
|
| 10 |
Huai G, Schuurman HJ, Cooper DKC, et al. Meeting report: xenotransplantation development conference in Neijiang, China[J]. Xenotransplantation, 2023, 30(6): e12829.
|
| 11 |
Tao KS, Yang ZX, Zhang X, et al. Gene-modified pig-to-human liver xenotransplantation[J]. Nature, 2025, 641(8064): 1029-1036.
|
| 12 |
空军军医大学西京医院. 基因编辑猪－终末期肾病患者肾脏移植再获突破[EB/OL]. (2026-05-23) [2026-06-14].
URL
|
| 13 |
First WHO Global Consultation on Regulatory Requirements for Xenotransplantation Clinical Trials: Changsha, China, 19-21 November 2008. The Changsha Communiqué[J]. Xenotransplantation, 2009, 16(2): 61-63.
|
| 14 |
Hawthorne WJ, Cowan PJ, Bühler LH, et al. Third WHO Global Consultation on Regulatory Requirements for Xenotransplantation Clinical Trials, Changsha, Hunan, China December 12-14, 2018: " the 2018 Changsha Communiqué" the 10-Year Anniversary of the International Consultation on Xenotransplantation[J]. Xenotransplantation, 2019, 26(2): e12513.
|
| 15 |
窦科峰，陶开山，李霄，等. 异种移植临床研究指导意见(2018建议版)[J]. 器官移植，2018, 9(6): 7-10.
|
| 16 |
窦科峰，陶开山，张玄，等. 异种器官移植亚临床研究专家共识(2024版)[J]. 器官移植，2024, 15(5): 653-660.
|
| 17 |
中国生物技术发展中心. 异种移植新技术临床研究备案指引(第1版)[EB/OL]. (2026-04-30) [2026-07-08].
URL
|
| 18 |
Griffith BP, Goerlich CE, Singh AK, et al. Genetically modified porcine-to-human cardiac xenotransplantation[J]. N Engl J Med, 2022, 387(1): 35-44.
|
| 19 |
Montgomery RA, Stern JM, Lonze BE, et al. Results of two cases of pig-to-human kidney xenotransplantation[J]. N Engl J Med, 2022, 386(20): 1889-1898.
|
| 20 |
Mohiuddin MM, Singh AK, Scobie L, et al. Graft dysfunction in compassionate use of genetically engineered pig-to-human cardiac xenotransplantation: a case report[J]. Lancet, 2023, 402(10399): 397-410.
|
| 21 |
eGenesis. eGenesis announces world′s first successful transplant of genetically engineered porcine kidney in a living patient[EB/OL]. (2024-03-21) [2026-06-14].
URL
|
| 22 |
Corporation UT. United Therapeutics Corporation announces first transplant in EXPAND clinical trial of UKidney in patients with end-stage renal disease[EB/OL]. (2025-11-03) [2026-06-14].
URL
|
| 23 |
Firl DJ, Markmann JF. Measuring success in pig to non-human-primate renal xenotransplantation: systematic review and comparative outcomes analysis of 1 051 life-sustaining NHP renal allo- and xeno-transplants[J]. Am J Transplant, 2022, 22(6): 1527-1536.
|
| 24 |
Cooper DK, Keogh AM, Brink J, et al. Report of the Xenotransplantation Advisory Committee of the International Society for Heart and Lung Transplantation: the present status of xenotransplantation and its potential role in the treatment of end-stage cardiac and pulmonary diseases[J]. J Heart Lung Transplant, 2000, 19(12): 1125-1165.
|
| 25 |
Mohiuddin MM, Singh AK, Corcoran PC, et al. Chimeric 2C10R4 anti-CD40 antibody therapy is critical for long-term survival of GTKO.hCD46.hTBM pig-to-primate cardiac xenograft[J]. Nat Commun, 2016, 7: 11138.
|
| 26 |
Längin M, Mayr T, Reichart B, et al. Consistent success in life-supporting porcine cardiac xenotransplantation[J]. Nature, 2018, 564(7736): 430-433.
|
| 27 |
Mohiuddin MM, Goerlich CE, Singh AK, et al. Progressive genetic modifications of porcine cardiac xenografts extend survival to 9 months[J]. Xenotransplantation, 2022, 29(3): e12744.
|
| 28 |
Parent B, Gelb B, Latham S, et al. The ethics of testing and research of manufactured organs on brain-dead/recently deceased subjects[J]. J Med Ethics, 2020, 46(3): 199-204.
|
| 29 |
Administration UFaD. Source animal, product, preclinical, and clinical issues concerning the use of xenotransplantation products in humans[EB/OL]. (2016-12-01) [2026-06-15].
URL
|
| 30 |
Denner J, Tönjes RR, Takeuchi Y, et al. First update of the International Xenotransplantation Association consensus statement on conditions for undertaking clinical trials of porcine islet products in type 1 diabetes-Chapter 5: recipient monitoring and response plan for preventing disease transmission[J]. Xenotransplantation, 2016, 23(1): 53-59.
|
| 31 |
Jagdale A, Kumar V, Anderson DJ, et al. Suggested patient selection criteria for initial clinical trials of pig kidney xenotransplantation in the United States[J]. Transplantation, 2021, 105(9): 1904-1908.
|
| 32 |
Entwistle JW, Sade RM, Drake DH. Clinical xenotransplantation seems close: ethical issues persist[J]. Artif Organs, 2022, 46(6): 987-994.
|
| 33 |
Padilla LA, Hurst DJ, Jang K, et al. Racial differences in attitudes to clinical pig organ xenotransplantation[J]. Xenotransplantation, 2021, 28(2): e12656.
|
| 34 |
Khush KK, Bernat JL, Pierson RN, et al. Research opportunities and ethical considerations for heart and lung xenotransplantation research: a report from the National Heart, Lung, and Blood Institute Workshop[J]. Am J Transplant, 2024, 24(6): 918-927.
|
| 35 |
Cooper DKC, Habibabady Z, Kinoshita K, et al. The respective relevance of sensitization to alloantigens and xenoantigens in pig organ xenotransplantation[J]. Hum Immunol, 2023, 84(1): 18-26.
|
| 36 |
Corr M, Walker A, Maxwell AP, et al. Non-adherence to immunosuppressive medications in kidney transplant recipients - a systematic scoping review[J]. Transplant Rev (Orlando), 2025, 39(1): 100900.
|
| 37 |
Coglianese EE, Samsi M, Liebo MJ, et al. The value of psychosocial factors in patient selection and outcomes after heart transplantation[J]. Curr Heart Fail Rep, 2015, 12(1): 42-47.
|
| 38 |
Bobier C, Rodger D, Hurst DJ. Xenotransplantation and lifelong monitoring[J]. Am J Transplant, 2024, 24(4): 697-698.
|
| 39 |
Hurst DJ, Padilla LA, Trani C, et al. Recommendations to the IRB review process in preparation of xenotransplantation clinical trials[J]. Xenotransplantation, 2020, 27(2): e12587.
|
| 40 |
Silverman H, Odonkor PN. Reevaluating the ethical issues in porcine-to-human heart xenotransplantation[J]. Hastings Cent Rep, 2022, 52(5): 32-42.
|